Repricings, div recaps no sweat for levloans, but no flood expected

Aggressive-looking leveraged loan deals for BSN Medical and RAC looked set for success this week as the lack of loan paper weighs on investors. But although bankers expect more companies to try repricings and dividend recaps, they do not see a wave of similar deals coming to market simply because there are not enough credits that are willing and able to carry out such transactions.